Top Stories

'Uncertainty kills deals, 1,000%,' Houlihan Lokey's Nate Pund told PE Hub.

One Equity Partners recently acquired EthosEnergy from John Wood Group and Siemens.

Archimed, KKR and Novo Holdings are among the PE firms investing in pharma research, development and sales for genetic medicine.

Providence Equity Partners, CVC and KKR are among the firms making deals in the live entertainment sector.

'Our thesis that these were all very strategic units was validated by the fact that we were able to exit all of them to a strategic home,' says Jon Nemo, AE Industrial managing partner.

InTandem is acquiring Healthfuse from New Capital Partners, PE Hub can reveal.

'Investments in niche, non-correlated assets are often smaller in scale, less competitive, and outcomes tend to be more dependent on idiosyncratic factors such as the supply chain for whiskey, the price of carbon, or federally insured crop insurance.'

The KKR complaint says: 'Now, on the eve of a leadership transition, the Antitrust Division has threatened a final act of agency overreach: the imposition of draconian and grossly disproportionate penalties on KKR based on alleged premerger paperwork errors that were immaterial to antitrust clearance.'

'You can’t get there without natural gas power generation.'

'There are half a trillion dollars in distributions that should have happened by now. LPs have been reminding GPs of this fact for a while, increasing pressure for more exits in 2025.'